ACRS financials
Aclaris Therapeutics (ACRS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ACRS income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $7.83M | $5.74M | -$76.38M | -$64.92M | -0.53 |
| 2024 | $18.72M | $15.93M | -$141.93M | -$132.06M | -1.71 |
| 2023 | $31.25M | $13.17M | -$97.36M | -$88.48M | -1.27 |
| 2022 | $29.75M | $17.79M | -$89.85M | -$86.91M | -1.33 |
| 2021 | $6.76M | $2.05M | -$89.72M | -$90.86M | -1.60 |
| 2020 | $6.48M | $1.35M | -$50.91M | -$51.02M | -1.20 |
- ACRS revenue was $7.83M in fiscal 2025, net income -$64.92M.
Updated 2026-11-07 11:55 UTC